New immune modulatory drugs for systemic lupus erythematosus--what can we expect?
Davidson
Anne
A
Departments of Medicine and Microbiology, Columbia University, 1130 St. Nicholas Avenue, New York NY 10032, USA. ad2247@columbia.edu
D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000276:immunology; D016896:Treatment Outcome
D007155:Immunologic Factors